Replies to post #196564 on Biotech Values

[tony111]

TEVA really needs to partner with MNTA for biosimilars. If FDA didn't spoon feed TEVA on characterizing enox, TEVA would never have got it approved. Teva would have got epipen approved long time ago with MNTA's characterization techniques.